BENGALURU, India , Aug. 11, 2025 /PRNewswire/ -- Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (OTCQX: ZCAR), the leading marketplace for self-drive car sharing in India, plans to report its financial and operating results for the Q1 FY 2025-26 ending June 30, 2025 before markets open on August 14, 2025. The Company will post the release on its Investor Relations website investor-relations.zoomcar.com.

– New Patient Screening for Phase 3 SENTRY Trial in Myelofibrosis Expected to Close This Week; Top-Line Results Anticipated in March 2026 – – Total Revenue was $37.9 Million; U.S. XPOVIO® (selinexor) Net Product Revenue was $29.7 Million, up 6% compared to Second Quarter of 2024 – – Reaffirms Full-Year 2025 Total Revenue Guidance of $140 Million to $155 Million; Updates U.S. XPOVIO Net Product Revenue Guidance to $110 Million to $120 Million – – The Company is Exploring Financing Transactions and Strategic Alternatives to Extend its Cash Runway and Maximize Value – – Conference Call Scheduled for Today at …

Robust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights All figures stated in this news release are in U.S. dollars unless stated otherwise.

BitMine is the largest ETH treasury in the world, 3rd largest crypto treasury globally BitMine ETH holdings of $4.96 billion ETH is a $2.0 billion increase from $2.9 billion reported last week BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital to support BitMine's goal of acquiring 5% of ETH BitMine now 25th most liquid US stock, trading $2.2 billion per day on average LAS VEGAS , Aug. 11, 2025 /PRNewswire/ -- (NYSE AMERICAN: BMNR) BitMine Immersion Technologies ("BitMine" or the "Company") today …

VANCOUVER, BC , Aug. 11, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced consolidated financial results for the second quarter ended June 30, 2025. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with International Financial Reporting Standards (IFRS).

CHICAGO , Aug. 11, 2025 /PRNewswire/ -- As previously announced, TDS will hold a teleconference on August 11, 2025, at 9:00 a.m. CDT. Listen to the call live via the Events & Presentations page of investors.tdsinc.com.

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today reports financial results for the second quarter of 2025 and highlighted major clinical, regulatory, and operational milestones supporting the advancement of its botensilimab (BOT) and balstilimab (BAL) immunotherapy combination. Botensilimab is a next-generation, multifunctional, Fc enhanced, CTLA-4 antibody and BAL is a proprietary PD-1 antibody; t.

PHILADELPHIA--(BUSINESS WIRE)--As the 2025–2026 school year begins, Aramark Collegiate Hospitality is responding to today's campus needs by listening closely and taking thoughtful action to align with each university's unique culture. From tailored food options to updated meal plans, Aramark shows that campus dining is about more than just meals—it's about building connection, community, and belonging. “Students are telling us what matters to them, and we're responding in real time,” said Jack.

Appointment recognizes Mr. Durso's extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH

Boca Raton, Florida--(Newsfile Corp. - August 11, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $3 million of pre-funded and common warrants. The entire transaction has been priced at the market under Nasdaq rules.

Successfully achieves high-purity germanium from recycled material and ore-based feedstock through internally developed flow sheet Targeting defense and advanced industrial partners requiring 99.9%-99.999% purity, sourced from virgin supply or customer-provided recycled feedstock Multi-mineral, multi-feedstock refining platform continues to set global benchmarks for versatility and efficiency FISHERS, IN / ACCESS Newswire / August 11, 2025 / American Resources Corporation's (NASDAQ:AREC) ("American Resources") through its holding in ReElement Technologies Corporation ("ReElement" or "RTC"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, today announced it has successfully developed commercial protocols to produce ultra-high-purity germanium from both recycled and …

The market's gains come from a tiny group of stocks. Owning the S&P 500 is safe, but boring. I prefer hunting overlooked winners. The S&P 500's dominance hides growing concentration risks. While Big Tech thrives on momentum, I prefer hunting in overlooked corners of the market, where strong fundamentals meet unjustified skepticism. My latest finds combine high yield, resilient cash flows, and secular tailwinds. Proof that you don't need to chase the crowd for quality.

I am downgrading ULTY to Hold due to its inferior long-term total returns and poor drawdown mitigation compared to alternatives like YMAX and DIY withdrawals from QQQ and SPY. YieldMax Ultra Option Income Strategy's option income strategy struggles to capture sharp innovation rallies and exposes investors to significant downside risk, undermining its income proposition. Recent outperformance is likely temporary, driven by a slow bull market; historical data shows ULTY underperforms over various market cycles.

Adjusted earnings per share came in at 0 cents on revenue of $1.4 billion, beating expectations.

Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will participate in a Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference in Boston, MA, on August 12, 2025, at 9:30 a.m. EDT. A live webcast of the Fireside Chat will be accessible under "Events & Presentations" in the Investors section of the Cardiol website (www.cardiolrx.com/investors/events-presentations/).

Adobe's margin outlook has improved, with net margins likely to surpass 30% in the upcoming quarter, alleviating my prior cost concerns from the Figma acquisition. I expect Adobe to begin consistently passing the Rule of 40 in the coming quarters. Adobe's current valuation is deeply discounted versus its own historical average and EV/sales ratios for companies with passing scores.

MPAA, OPFI and CZFS made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 11, 2025.

The WisdomTree International Hedged Quality Dividend Growth ETF (IHDG) was launched on 05/07/2014, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Developed World ETFs category of the market.

Making its debut on 11/08/2017, smart beta exchange traded fund John Hancock Multifactor Small Cap ETF (JHSC) provides investors broad exposure to the Style Box - Small Cap Blend category of the market.

Looking for broad exposure to the Technology - Semiconductors segment of the equity market? You should consider the Invesco PHLX Semiconductor ETF (SOXQ), a passively managed exchange traded fund launched on June 11, 2021.